MedTrace Logo

AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study

NCT04126187 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-09-21

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the spectacle independence of patients receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.

Conditions

  • Cataract

Interventions

DEVICE

Panoptix

Panoptix trifocal intraocular lens (IOL)

Sponsors & Collaborators

  • Science in Vision

    collaborator OTHER

  • Gainesville Eye Associates

    lead OTHER

Principal Investigators

  • Clayton G Blehm, MD · Gainesville Eye Associates

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-14
Primary Completion
2021-03-30
Completion
2021-03-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126187 on ClinicalTrials.gov